title: Posterior reversible encephalopathy syndrome due to combination of vemurafenib and cobimetinib for metastatic melanoma.
authors.affiliation: Department of Dermatology, University of Nice Sophia Antipolis, Nice, France.
authors.forename: Feriel
authors.initials: F
authors.lastname: Boukari
authors.affiliation: Department of Dermatology, University of Nice Sophia Antipolis, Nice, France.
authors.forename: Pierre Michel
authors.initials: PM
authors.lastname: Dugourd
authors.affiliation: Department of Radiology, University of Nice Sophia Antipolis, Nice, France.
authors.forename: Madleen
authors.initials: M
authors.lastname: Chassang
authors.affiliation: Department of Radiology, Pasteur Hospital, University of Nice Sophia Antipolis, Nice, France.
authors.forename: Lydiane
authors.initials: L
authors.lastname: Mondot
authors.affiliation: Department of Dermatology, University of Nice Sophia Antipolis, Nice, France.|INSERM, U1065, Centre Méditerranéen de Médecine Moléculaire, Team 12, Nice, France.
authors.forename: Thierry
authors.initials: T
authors.lastname: Passeron
authors.affiliation: Department of Dermatology, University of Nice Sophia Antipolis, Nice, France.
authors.forename: Jean-Philippe
authors.initials: JP
authors.lastname: Lacour
authors.affiliation: Department of Dermatology, University of Nice Sophia Antipolis, Nice, France.
authors.forename: Henri
authors.initials: H
authors.lastname: Montaudie
mesh_terms: D000368:Aged; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000009:adverse effects*; D001384:Azetidines / Q000009:adverse effects*; D001921:Brain / Q000000981:diagnostic imaging; D018450:Disease Progression; D006801:Humans; D007211:Indoles / Q000009:adverse effects*; D008207:Lymphatic Metastasis; D008279:Magnetic Resonance Imaging; D008297:Male; D008545:Melanoma / Q000150:complications* / Q000188:drug therapy; D010880:Piperidines / Q000009:adverse effects*; D054038:Posterior Leukoencephalopathy Syndrome / Q000139:chemically induced* / Q000175:diagnosis; D048493:Proto-Oncogene Proteins B-raf / Q000378:metabolism; D012878:Skin Neoplasms / Q000150:complications* / Q000188:drug therapy; D013449:Sulfonamides / Q000009:adverse effects*; D000077484:Vemurafenib
chemical_list: D001384:Azetidines; D007211:Indoles; D010880:Piperidines; D013449:Sulfonamides; D000077484:Vemurafenib; D048493:Proto-Oncogene Proteins B-raf; C574276:cobimetinib